As of Jul 02
| -0.51 / -0.73%|
The 5 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 70.00, with a high estimate of 80.00 and a low estimate of 62.00. The median estimate represents a +0.42% increase from the last price of 69.71.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.